Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Williston › NPI 1679819387
Hospital

Regional Health Partners LLC

Regional Health Partners LLC was paid $55K by Medicaid between Jan 2018 and May 2019, across 31 billing codes. Its largest line is 80348, — 99% of everything it billed.

33Billing provider infoREGIONAL HEALTH PARTNERS LLC
WILLISTON, FL 32696
33aNPI1679819387assigned 12/27/2012
28Total paid$55K
24GClaims6,292
24DCodes billed31
24AFirst – last monthJan 2018 – May 2019
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018460$770.75
20195,832$54K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80348 99% 344 320 $54K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 1.2% 16 15 $645.77
80053 Comprehensive metabolic panel <1% 32 31 $61.43
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 23 22 $41.31
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 58 56 $18.79
81001 <1% 13 12 $3.45
80366 0% 344 320 $0.00
80323 0% 344 320 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 0% 88 86 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 0% 344 320 $0.00
80356 0% 344 320 $0.00
80346 0% 344 320 $0.00
19 more codes
82374 0% 29 $0.00
82565 0% 14 $0.00
80345 0% 344 $0.00
80363 0% 344 $0.00
80371 0% 344 $0.00
80359 0% 344 $0.00
80358 0% 344 $0.00
84075 0% 13 $0.00
80320 0% 336 $0.00
80353 0% 344 $0.00
80350 0% 344 $0.00
36415 Collection of venous blood by venipuncture 0% 53 $0.00
94760 0% 15 $0.00
80349 0% 336 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 73 $0.00
80368 0% 344 $0.00
80324 0% 344 $0.00
82040 0% 12 $0.00
87086 Culture, bacterial; quantitative colony count, urine 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMEARS, EDITH (CEO)
Parent organizationREGIONAL HEALTH PARTNERS LLC